Medicofarma Biotech (WAR:MDB) ROCE % : -0.89% (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Medicofarma Biotech ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medicofarma Biotech's annualized ROCE % for the quarter that ended in Mar. 2024 was -0.89%.

Medicofarma Biotech ROCE % Historical Data

The historical data trend for Medicofarma Biotech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicofarma Biotech ROCE % Chart

Medicofarma Biotech Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

3.33

-39.35

-381.74

-2.89

-11.81

Medicofarma Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
ROCE %	Get a 7-Day Free Trial															-10.14	-19.09	-19.37	-15.81	-0.89

Medicofarma Biotech ROCE % Calculation

Medicofarma Biotech's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-1.583	/	( ( (16.768 - 2.565)	+	(16.37 - 3.756) )	/ 2 )
	=	-1.583	/	( (14.203	+	12.614)	/ 2 )
	=	-1.583	/	13.4085
	=	-11.81 %

Medicofarma Biotech's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Sep. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Sep. 2023 )		(Q: Mar. 2024 )
	=	-0.1	/	( ( (15.757 - 4.776)	+	(15.592 - 4.002) )	/ 2 )
	=	-0.1	/	( ( 10.981	+	11.59 )	/ 2 )
	=	-0.1	/	11.2855
	=	-0.89 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Medicofarma Biotech (WAR:MDB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medicofarma Biotech ROCE % Related Terms

Thank you for viewing the detailed overview of Medicofarma Biotech's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicofarma Biotech (WAR:MDB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicofarma Biotech SA (WAR:MDB) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Soko?owska 9 lok. U19, Warsaw, POL, 01-142

Website

https://www.medicofarma.pl

Medicofarma Biotech SA operates in the pharmaceutical industry. The company specializes in contract manufacturing of medical devices, medicinal products and dietary supplements. The business is spread across Austria, Czech Republic, Spain, Ireland, Canada, Germany, Norway, Sweden, Great Britain, and Italy.